amyloid-beta-SM (ICB International)

N/A

Report date: 2025/01/26 19:00:46

Base Information

Drug Nameamyloid-beta-SM (ICB International)
Drug Alias Nameamyloid-beta targeting antibody (ICB International)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionBeta amyloid A4 protein modulators
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIcb International Inc
China Registration ClassN/A

Develop Information

Active CompaniesIcb International Inc
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A